Ignite Creation Date:
2024-05-06 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05209152
Status:
COMPLETED
Last Update Posted:
2024-04-30
First Post:
2022-01-13
Brief Title:
AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-13
First Submit QC Date:
January 13 2022
Study First Post Date:
2022-01-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-26
Last Update Post Date:
2024-04-30
Last Update Post Date Type:
ACTUAL